Hospital discharges for malignant neoplasm of the prostate in Australia have shown fluctuating trends between 2013 and 2023. As of 2023, the value stood at 18.57 thousand discharges. Over the past decade, the data reflects periods of significant increases and minor decreases. Notably, between 2018 and 2019, there was a 5.81% increase, while a minor 1.46% drop occurred in 2020. From 2021 to 2023, the year-on-year growth rate stabilized to around 1%. The Compound Annual Growth Rate (CAGR) from 2018 to 2023 was 1.46%, indicating a steady growth over five years.

Forecasts from 2024 to 2028 project a continuation of this upward trend, although at a slower pace, with a five-year forecast CAGR of 0.58%, anticipating a total growth rate of 2.94% by 2028. This suggests a moderated increase in hospital discharges for malignant neoplasm of the prostate.

Future trends to watch for:

Advancements in prostate cancer treatments may impact the hospital discharge rates.
Early detection and preventive measures might reduce the need for hospitalizations.
Public health policies and awareness programs could significantly alter these projections.